Variables | Recurrence | Overall survival | ||
---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | |
Age (> 50 years versus ≤ 50 years) | 0.73 (0.50–1.07) | 0.104 | 0.64 (0.41–1.02) | 0.060 |
Sex (male versus female) | 0.76 (0.48–1.21) | 0.249 | 1.16 (0.69–1.95) | 0.563 |
Liver cirrhosis (yes versus no) | 1.52 (0.92–2.49) | 0.099 | 1.11 (0.63–1.96) | 0.712 |
ALT (> 40 U/L versus ≤ 40 U/L) | 1.57 (1.06–2.34) | 0.025 | 1.8 (0.85–2.24) | 0.190 |
AST (> 40 U/L versus ≤40 U/L) | 1.78 (1.20–2.64) | 0.004 | 1.49 (0.92–2.41) | 0.101 |
AFP (> 400 ng/ml versus ≤ 400 ng/ml) | 1.86 (1.25–2.78) | 0.002 | 1.49 (0.91–2.43) | 0.117 |
No. of tumors (multi versus single) | 1.81 (1.06–3.08) | 0.030 | 1.57 (0.84–3.02) | 0.157 |
Tumor size (> 5 cm versus ≤ 5 cm) | 2.35 (1.60–3.43) | < 0.001 | 1.59 (0.99–2.48) | 0.056 |
Tumor encapsulation (none versus complete) | 1.15 (0.78–1.69) | 0.452 | 1.03 (0.64–1.67) | 0.903 |
Satellite lesions (yes versus no) | 1.67 (0.96–2.88) | 0.069 | 0.78 (0.33–1.76) | 0.528 |
Macrovascular invasion (yes versus no) | 2.30 (1.28–4.12) | 0.005 | 2.19 (1.13–4.28) | 0.021 |
Microvascular invasion (yes versus no) | 2.08 (1.42–3.04) | < 0.001 | 1.91 (1.21–3.04) | 0.006 |
Edmondson stage (III–IV versus I–II) | 1.78 (1.21–2.61) | 0.003 | 1.50 (0.94–2.39) | 0.087 |
BCLC stage (B + C versus 0 + A) | 1.98 (1.27–3.09) | 0.003 | 1.72 (1.01–2.94) | 0.045 |
ALBI grade (II versus I) | 1.23 (0.80–1.89) | 0.344 | 1.86 (1.12–3.09) | 0.017 |
CD73 (high versus low) | 2.33 (1.59–3.42) | < 0.001 | 3.64 (2.20–6.01) | < 0.001 |